March 5, 2025
TOPLINE: Real-world treatment patterns and outcomes among older patients with follicular lymphoma show significant heterogeneity, with 13,423 Medicare beneficiaries aged ≥ 65 years followed through 2019. […]
March 5, 2025
The US Food and Drug Administration has approved tislelizumab (Tevimbra, BeiGene), in combination with platinum-containing chemotherapy, for the first-line treatment of adults with unresectable or metastatic […]
March 4, 2025
More than a quarter of pupils are missing out on the human papillomavirus (HPV) vaccine, leaving many at risk of cancer, a new report has found. […]
March 4, 2025
TOPLINE: A default palliative care referral intervention increased palliative care consultations by more than fivefold and decreased end-of-life systemic therapy by more than half among patients […]
March 4, 2025
Tens of thousands of patients with lung cancer in the United Kingdom are missing out on targeted treatment that could improve their prognosis due to delays […]
March 4, 2025
Hepatocellular carcinoma (HCC), the most common type of liver cancer, affects women and men at similar rates in Mexico; however, men are more likely to present […]
March 3, 2025
The National Institute for Health and Care Excellence (NICE) has published a final draft guidance recommending efanesoctocog alfa for treating and preventing bleeding episodes in people aged […]
March 3, 2025
TOPLINE: Targeted axillary dissection (TAD) emerged as the optimal minimally invasive technique, demonstrating superior diagnostic accuracy over other approaches in patients with node-positive breast cancer receiving […]
March 3, 2025
TOPLINE: Lentiviral vector (LV)–based gene therapy using CD34+ hematopoietic stem cells (HSCs) demonstrated stable factor VIII expression in severe hemophilia A patients, with higher vector copy […]